ROYAL CRESCENT SURGERY — All Prescriptions & Medications
Practice Code: L84059 | CHELTENHAM, GL52 3EY
Over the last 12 months, ROYAL CRESCENT SURGERY prescribed 149,884 items across 516 different medications at a total cost of £1,129,291 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mebeverine hydrochloride compound preparations | 10 | 300 | £261 | -11.6% ▼ |
| Valsartan with diuretic | 10 | 476 | £287 | -24.5% ▼ |
| Codeine phosphate | 10 | 2,600 | £27 | -30.3% ▼ |
| Ivermectin | 10 | 68 | £850 | +2.5% ▲ |
| Metformin hydrochloride/vildagliptin | 10 | 600 | £339 | -38.8% ▼ |
| Oral rehydration salts | 10 | 90 | £40 | -65.4% ▼ |
| Hydrocort sodiumphos | 10 | 300 | £105 | +30.6% ▲ |
| 10 | 10 | £50 | -80.5% ▼ | |
| 10 | 100 | £273 | -79.1% ▼ | |
| 10 | 100 | £107 | -87.1% ▼ | |
| 10 | 300 | £1.1K | +16.8% ▲ | |
| 10 | 210 | £1.5K | +14.3% ▲ | |
| Frovatriptan | 11 | 114 | £292 | -22.2% ▼ |
| Biphasic insulin lispro | 11 | 115 | £688 | -74.4% ▼ |
| Sodium feredetate | 11 | 5,090 | £145 | -61.6% ▼ |
| Other health supplement preparations | 11 | 660 | £69 | -76.8% ▼ |
| Mefenamic acid | 11 | 647 | £120 | -75.7% ▼ |
| Adapalene | 11 | 495 | £172 | -49.7% ▼ |
| Malathion | 11 | 2,700 | £246 | +72.2% ▲ |
| Other toiletry preparations | 11 | 3,200 | £72 | -74.2% ▼ |
| 11 | 55 | £145 | -54.6% ▼ | |
| Nizatidine | 12 | 1,050 | £664 | -65.1% ▼ |
| Amisulpride | 12 | 672 | £243 | -82.9% ▼ |
| Doxycycline monohydrate | 12 | 764 | £405 | +10.5% ▲ |
| Powder thickener - starch based (0913161) | 12 | 1,620 | £46 | -16.5% ▼ |
| Dantrolene sodium | 12 | 504 | £82 | -33.5% ▼ |
| Hypromellose | 12 | 120 | £31 | -90.9% ▼ |
| Heparinoid | 12 | 600 | £46 | -8.0% ▼ |
| 12 | 129 | £14 | -59.8% ▼ | |
| 12 | 138 | £874 | -43.2% ▼ | |
| 12 | 160 | £497 | -63.2% ▼ | |
| 12 | 360 | £893 | -21.2% ▼ | |
| Budesonide | 13 | 1,208 | £908 | -17.0% ▼ |
| Ursodeoxycholic acid | 13 | 2,068 | £230 | -80.4% ▼ |
| Linagliptin | 13 | 728 | £822 | -96.8% ▼ |
| Febuxostat | 13 | 364 | £28 | -65.2% ▼ |
| Aciclovir | 13 | 36 | £33 | +5.4% ▲ |
| 13 | 390 | £641 | +64.3% ▲ | |
| 13 | 390 | £727 | +1.6% vs avg | |
| 13 | 904 | £63 | -94.0% ▼ | |
| Naldemedine | 14 | 392 | £555 | +59.4% ▲ |
| Enoxaparin | 14 | 158 | £689 | -31.7% ▼ |
| Aripiprazole | 14 | 14 | £3.1K | -8.1% ▼ |
| Cinnarizine | 14 | 1,176 | £53 | -70.1% ▼ |
| Clonidine hydrochloride | 14 | 2,624 | £4.9K | -73.8% ▼ |
| Procyclidine hydrochloride | 14 | 1,176 | £54 | -90.1% ▼ |
| Vardenafil | 14 | 144 | £297 | +0.3% vs avg |
| Mercaptopurine | 14 | 350 | £158 | -9.6% ▼ |
| Diethylamine salicylate | 14 | 950 | £30 | -48.1% ▼ |
| Ciprofloxacin | 14 | 210 | £80 | +51.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.